(MedPage Today) — An investigational anticoagulant that targets factor XI failed to prevent arteriovenous graft (AVG) thrombosis in chronic hemodialysis patients, according to a placebo-controlled phase IIb trial.
In 502 patients with end-stage…
Source link : https://www.medpagetoday.com/meetingcoverage/era/115952
Author :
Publish date : 2025-06-06 21:43:00
Copyright for syndicated content belongs to the linked Source.
